• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Verici Dx PLC (VRCI)

ORD GBP0.001
Sell: 0.20p|Buy: 0.21p|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Company profile

Verici Dx PLC is the development of prognostic and diagnostic tests for kidney transplant patients. It is a commercial stage diagnostics company, transforming the outcomes of kidney transplants through a complementary suite of proprietary,edge tests. These form a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. It has developed a suite of blood-based tests for kidney transplant patients. The group has one division being the development of prognostic and diagnostic tests for kidney transplant patients. The company's products are Tutivia, Clarava, Protega. The company's services are Next Generation Sequencing Services, Bioinformatics and Data Science Services.

Address

19 Stanwell Road
Avon House
Cardiff
GBR
CF64 2EZ

Telephone

+44 2920710570

Website

https://www.vericidx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Verici Dx PLC Second Quarter Earnings Results for 20272027-09-30T00:00:00
Verici Dx PLC Annual General Meeting for 20272027-07-28T10:30:00
Verici Dx PLC Fourth Quarter Earnings Conference Call for 20262027-07-08T15:30:00
Verici Dx PLC Fourth Quarter Earnings Results for 20262027-06-29T00:00:00
Verici Dx PLC Annual Report for 20262027-06-29T00:00:00

Previous key dates

NameKey Date
Verici Dx PLC Second Quarter Earnings Results for 20262026-09-30T00:00:00
Verici Dx PLC Annual General Meeting for 20262026-07-28T10:30:00
Verici Dx PLC Fourth Quarter Earnings Conference Call for 20252026-07-08T15:30:00
Verici Dx PLC Fourth Quarter Earnings Results for 20252026-06-29T00:00:00
Verici Dx PLC Annual Report for 20252026-06-29T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.